0.035 inch stiff guide wire

Manufactured by Cook Medical

Sourced in United States

The 0.035-inch stiff guide wire is a medical device designed to facilitate the insertion and positioning of catheters or other interventional devices within the human body. It is a thin, flexible wire with a stiff core, intended to provide support and guidance during medical procedures.

Automatically generated - may contain errors

Lab products found in correlation

Normal guidewire, by Cook Medical (2 mentions) 0.035 inch normal guidewire, by Terumo (2 mentions) 21g chiba needle, by Cook Medical (2 mentions) 4f angiographic catheter, by Cordis (2 mentions) 4f ver catheter, by Cordis (1 mentions) 0.035 inch soft guide wire, by Terumo (1 mentions)

Spelling variants of this product

Guide wire (6 citations) Stiff guide wires (2 citations)

4 protocols using 0.035 inch stiff guide wire

Transhepatic Biliary Stent Placement

Check if the same lab product or an alternative is used in the 5 most similar protocols

Patients were placed in a supine position. The right intrahepatic biliary tract was punctured under combined ultrasonic and fluoroscopic guidance. A 0.035-inch normal guidewire (Terumo, Tokyo, Japan) and a 4 to 5F VER catheter (Cordis, Hialeah, FL) were used to detect the obstructed site. When the guidewire and catheter had entered the duodenum, the normal guidewire was exchanged with a 0.035-inch stiff guidewire (Cook, Bloomington, IN). The uncovered SEMS (Micro-Tech, Nanjing, China) was placed at the obstructed site via this stiff guidewire. The stents were 8 mm in diameter and 50 to 70 mm in length.
All patients received antibiotic therapy and hemostasis for 3 to 5 days after SEMS insertion

Yang S.Y., Liu F., Liu Y., Xia F.F, & Fu Y.F. (2020). Stent insertion with high-intensity focused ultrasound ablation for distal biliary obstruction secondary to pancreatic carcinoma. Medicine, 99(6), e19099.

+ Open protocol

+ Expand

Bare and Covered Stents for Malignant Biliary Obstruction

Check if the same lab product or an alternative is used in the 5 most similar protocols

Both bare and covered stents were inserted under the fluoroscopic guidance. The methods of bare and covered stents insertion were same. A 21G Chiba needle (Cook, Bloomington, IN) was punctured into the intrahepatic biliary tract via the right approach. The contrast-medium was injected into the biliary tract to confirm the DMBO site and the length of obstruction. A 4F angiographic catheter (Cordis, Warren, FL) with a 0.035-inch normal guide wire (Terumo, Tokyo, Japan) was then employed to pass through the obstruction. When the catheter and guide wire entered the duodenum, a 0.035-inch stiff guide wire (Cook) was used to replace the normal guide wire. The stent introducer sheaths were sent to the DMBO site via the stiff guide-wire and the stents were released to recanalize the obstruction.
All patients were placed an 8.5F temporary biliary drainage catheter (Cook) and administered preventive anti-inflammatory medications and hemostasis for 5 days.

Tang L., Bao K.H., Xu Y.S, & Liu P.H. (2021). Covered vs bare stent for distal malignant biliary obstruction due to primary common biliary cancer. Medicine, 100(3), e23938.

+ Open protocol

+ Expand

Percutaneous Biliary Obstruction Stenting

Check if the same lab product or an alternative is used in the 5 most similar protocols

All procedures were performed with fluoroscopic guidance. A 21G Chiba needle (Cook, IN, USA) was used to puncture the right intrahepatic biliary tract using combined ultrasonic and fluoroscopic guidance, with cholangiography being conducted to image the obstruction. A 4F VER catheter (Cordis, Warren, FL, USA) with a 0.035-inch normal guide wire (Terumo, Tokyo, Japan) was then employed to pass through the obstruction. When the catheter and guide wire entered the duodenum, a 0.035-inch stiff guide wire (Cook) was used to replace the normal guide wire. The stent (Micro-Tech, Nanjing, China) was released at the site of the obstruction via the stiff guide wire.

Gao F.L., Wang Y., Lu J., Zhu G.Y., Huang X.Z., Ren D.Q, & Guo J.H. (2021). Insertion of I-125 seed-loaded stent for inoperable hilar cholangiocarcinoma. Videosurgery and other Miniinvasive Techniques, 16(4), 678-685.

+ Open protocol

+ Expand

Celiac Artery Aneurysm Stenting Procedure

Check if the same lab product or an alternative is used in the 5 most similar protocols

Fluoroscopic guidance and local anesthesia were used during all stent insertion procedures in this study. All procedures were performed in the digital substraction angiography room.
The treatment was performed via a right femoral approach. A 5F vascular sheath was inserted into the right femoral artery, a 0.035-inch soft guide wire (Terumo, Tokyo, Japan) and a 4F angiographic catheter (Cordis, NJ, USA) were inserted to the vascular sheath, and the angiographic catheter was placed at the ostium of the celiac artery.
CAA was confirmed via celiac angiography, after which the guide wire was exchanged for 0.035-inch stiff guide wire (Cook, IN, USA). This guide wire was then used to insert a metal stent which was used to seal the CAA (Fig. 1b). Stent selection criteria were: (a) stents had to fully cover the CAA neck (a minimum of 5 mm on both sides), and (b) the stent had a diameter that was 1.1–1.2 times the celiac artery diameter. After stent insertion was complete, patency was confirmed and CAA was reevaluated via celiac angiography.
For 6 months following intervention, all patients underwent dual anti-platelet treatment (aspirin 100 mg/day + clopidogrel 75 mg/day), after which daily aspirin intake was maintained for life.

Yuan F.K., Xi H.L., Qin R.H., Tian Z.L., Li C, & Lu F. (2020). Endovascular treatment with stenting of celiac artery aneurysms. Medicine, 99(48), e23448.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!